|
PIGG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.160900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.722900E-03 |
| Normal-vs-Stage2 |
1.331420E-01 |
| Normal-vs-Stage3 |
1.325610E-01 |
| Normal-vs-Stage4 |
5.134300E-02 |
| Stage1-vs-Stage2 |
5.828600E-01 |
| Stage1-vs-Stage3 |
6.734000E-01 |
| Stage1-vs-Stage4 |
8.586000E-01 |
| Stage2-vs-Stage3 |
9.065000E-01 |
| Stage2-vs-Stage4 |
6.136200E-01 |
| Stage3-vs-Stage4 |
7.257000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.021650E-02 |
| Normal-vs-AfricanAmerican |
1.951570E-02 |
| Normal-vs-Asian |
3.919200E-01 |
| Caucasian-vs-AfricanAmerican |
6.734400E-01 |
| Caucasian-vs-Asian |
7.323600E-01 |
| AfricanAmerican-vs-Asian |
8.378000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.135600E-03 |
| Normal-vs-Female |
1.151820E-01 |
| Male-vs-Female |
2.207800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.117000E-03 |
| Normal-vs-Extreme_Weight |
8.420500E-03 |
| Normal-vs-Obese |
6.347700E-02 |
| Normal-vs-Extreme_Obese |
1.608070E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.004600E-01 |
| Normal_Weight-vs-Obese |
3.670200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.502400E-01 |
| Extreme_Weight-vs-Obese |
3.720600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.054400E-01 |
| Obese-vs-Extreme_Obese |
4.039400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.847000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.107590E-01 |
| Normal-vs-Age(61-80Yrs) |
1.159090E-03 |
| Normal-vs-Age(81-100Yrs) |
1.361460E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.523800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.418800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.163750E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.543700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.119800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.118200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.510360E-02 |
| Normal-VS-Type2 PRCC |
2.522200E-03 |
| Normal-VS-KIRP CIMP |
1.013980E-01 |
| Normal-VS-Unclassified PRCC |
7.703600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.232580E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.194800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.058380E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.497200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.510400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.318240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.9171000000009E-05 |
| Normal-vs-N1 |
3.457200E-01 |
| Normal-vs-N2 |
1.820250E-01 |
| N0-vs-N1 |
1.993000E-01 |
| N0-vs-N2 |
7.519200E-01 |
| N1-vs-N2 |
7.179200E-01 |
|
|
